Next Generation Cancer Diagnostics Market Size,
Revenue, Share and Growth Rate to 2024
The Next generation cancer diagnostics Market report provides in-depth analysis and insights into developments
impacting businesses and enterprises on global and regional level. The report covers the global Next generation cancer
diagnostics Market performance in terms of revenue contribution from various segments and includes a detailed
analysis of key trends, drivers, restraints, and opportunities influencing revenue growth of the global Next generation
cancer diagnostics market. This report studies the global Next generation cancer diagnostics Market size, industry status
and forecast, competition landscape and growth opportunity. This research report categorizes the global Next
generation cancer diagnostics Market by companies, region, type and end-use industry.
Global next generation cancer diagnostics market size was worth USD 4,964.05 million in 2016 which is anticipated to
grow at a CAGR of more than 9.7% over the forecast period. Rise in mortality rate due to the increasing occurrence of
the cancer, second most predominant disease accounting for approximately 8.8 million deaths in 2015 is anticipated to
escalate the market for these tests.
Advancements in tests enable early diagnosis and assist efficient detection of different types of tumors which in turn is
expected to promote growth over the projected period. The introduction of new products by large bodies, merger, and
acquisitions, and joint agreements such as the development of RNA-Seq Kit version by Agilent Technologies Inc. and
Agendia Inc. are the factors accountable for the estimated CAGR.
An escalation in the development of companion diagnostics in order to deliver advanced and personalized genomic
medicine is also responsible for progress in the coming years.
Request Sample Copy of This Market Research @